Conmed (CNMD) Return on Capital Employed Growth (1y) (2012 - 2026)
Conmed (CNMD) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.00 |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn | -345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -345.00 |
| Dec 31, 2025 | -475.00 |
| Sep 30, 2025 | -392.00 |
| Jun 30, 2025 | 53.00 |
| Mar 31, 2025 | 188.00 |
| Dec 31, 2024 | 383.00 |
| Sep 30, 2024 | 625.00 |
| Jun 30, 2024 | 479.00 |
| Mar 31, 2024 | 407.00 |
| Dec 31, 2023 | 252.00 |
| Sep 30, 2023 | -193.00 |
| Jun 30, 2023 | -320.00 |
| Mar 31, 2023 | -402.00 |
| Dec 31, 2022 | -351.00 |
| Sep 30, 2022 | -68.00 |
| Jun 30, 2022 | -1.00 |
| Mar 31, 2022 | 368.00 |
| Dec 31, 2021 | 406.00 |
| Sep 30, 2021 | 301.00 |
| Jun 30, 2021 | 385.00 |